Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 12:53 pm Sale | 13G | Loxo Oncology Inc. LOXO | SANDS CAPITAL MANAGEMENT LLC | 0 0% | -1,722,467![]() (Position Closed) | View |
2020-01-08 3:11 pm Sale | 13G | Loxo Oncology Inc. LOXO | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -1,793,587![]() (Position Closed) | View |
2019-02-15 4:05 pm Sale | 13D | Loxo Oncology Inc. LOXO | AISLING CAPITAL III LP | 0 0% | -2,038,920![]() (Position Closed) | View |
2019-02-14 1:51 pm Purchase | 13G | Loxo Oncology Inc. LOXO | PRICE T ROWE ASSOCIATES INC | 2,116,328 6.9% | 521,191![]() (+32.67%) | View |
2019-02-13 2:08 pm Sale | 13G | Loxo Oncology Inc. LOXO | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,543,192![]() (Position Closed) | View |
2019-02-12 09:58 am Sale | 13G | Loxo Oncology Inc. LOXO | WELLINGTON MANAGEMENT GROUP LLP | 1,793,587 5.86% | -298,564![]() (-14.27%) | View |
2019-02-11 1:59 pm Purchase | 13G | Loxo Oncology Inc. LOXO | VANGUARD GROUP INC | 2,789,978 9.11% | 817,059![]() (+41.41%) | View |
2019-02-11 09:14 am Sale | 13G | Loxo Oncology Inc. LOXO | FMR LLC | 414,902 1.349% | -1,582,428![]() (-79.23%) | View |
2019-02-08 12:33 pm Sale | 13G | Loxo Oncology Inc. LOXO | FMR LLC | 1,997,330 6.524% | -303,372![]() (-13.19%) | View |
2019-02-06 3:03 pm Purchase | 13G | Loxo Oncology Inc. LOXO | BlackRock Inc. BLK | 2,280,968 7.5% | 439,632![]() (+23.88%) | View |
2019-01-15 4:08 pm Purchase | 13D | Loxo Oncology Inc. LOXO | ELI LILLY & Co LLY | 2,038,920 6.6% | 2,038,920![]() (New Position) | View |
2019-01-15 08:30 am Unchanged | 13D | Loxo Oncology Inc. LOXO | AISLING CAPITAL III LP | 2,038,920 6.7% | 0 (Unchanged) | View |
2019-01-10 3:25 pm Sale | 13G | Loxo Oncology Inc. LOXO | SANDS CAPITAL MANAGEMENT LLC | 1,722,467 5.6% | -549,642![]() (-24.19%) | View |
2018-07-12 4:45 pm Sale | 13D | Loxo Oncology Inc. LOXO | AISLING CAPITAL III LP | 2,038,920 6.8% | -1,650,000![]() (-44.73%) | View |
2018-07-10 10:52 am Sale | 13G | Loxo Oncology Inc. LOXO | FMR LLC | 2,300,702 7.649% | -2,189,923![]() (-48.77%) | View |
2018-06-05 6:41 pm Sale | 13D | Loxo Oncology Inc. LOXO | ACCESS INDUSTRIES MANAGEMENT LLC | 857,982 2.85% | -883,535![]() (-50.73%) | View |